Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

La Caixa and VHIR sign an greement for post-MIR grant

La Caixa, through 'Obra Social', and Vall d'Hebron Research Institute (VHIR) signed today an agreement whereby the bank will continue funding a post-MIR grant to our center. Thanks to the 60,000 euros that provides La Caixa, one of our researchers will enjoy two years of significant help to do a the

News

Dr. Ávila, member of VHIR's CCE, new director of CIBERNED

Dr. Jesús Avila, member of the External Scientific Council (CEC) of Vall d'Hebron Research Institute (VHIR) has been chosen as the new director of Biomedical Network Research Center in Neurodegenerative Diseases (CIBERNED). Dr. Avila's work focuses on the study of neurodegenerative processes of Alzh

News

Interview with Dr. Miguel Marin Padilla, one life devoted to human brain

On October 5 Dr. Miguel Marin Padilla, from the Department of Pathology at Dartmouth Medical School in Hanover, USA, visited us during a general clinical session of Neurosciences invited by Dr. Alfons Macaya, head of the pediatric neurology group at Vall d'Hebron Research Institute (VHIR). Hours lat

News

Dr. Rafael Simó and the keys of diabetes disease at Catalunya Radio

On Friday October 7 the radio show 'El Cafè de la República' presented and directed by Joan Barril at Catalunya Radio, issued a lengthy interview with Dr. Rafael Simó, head of the diabetes and metabolism group at Vall d'Hebron Research Institute (VHIR), who discussed general aspects of the diabetes

News

VHIR's CRIPS group awarded at ESICM 2011

The Clinical Research/Innovation in Pneumonia & Sepsis group (CRIPS) at Vall d'Hebron Research Institute (VHIR) participated this week in the 24th annual congress of the European Society of Intensive Care (ESICM 2011) which took place in Berlin. Crips presented 9 abstracts, one of which, a cooperati

News

Discovery of a new genetic mechanism responsible for cardiac hypertrophy

A research network with Catalan participation and in which have worked researchers from seven countries has discovered how to control cardiac hypertrophy, increased heart weight that may lead to heart failure, a major cause of death and disability worldwide. This study, which was coordinated by Dr.

News

Delegates of Mondragon visit VHIR to initiate collaborative works between the two entities

After the cooperation agreement signed on 4 July between Mondragon Health and Vall d'Hebron to collaborate in the field of R+D+I, representatives of the Basque company have visited Vall d'Hebron Research Institute (VHIR) to begin the working sessions between the two entities. By Mondragon were prese

News

4th SMD Integrated Diagnostic Workshop

Units of Cytology, Immunophenotype and cytogenetics of Hematology from Hospital Vall d'Hebron organized on October 5 the fourth Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases.The workshop third edition, led by Dr Teresa Vallespí, hematologist of Vall d'Hebron Resea

News

Dr. Ricard Pujol reflects on the Nobel Prize in Medicine 2011

Nobel Prize in Medicine 2011 recognize key contributions that have revolutionized immunology over the last 15 years It's a truism that science advances with each change of paradigm, but it's true, and this year's honorees have been key players in a very significant change in the conception of the fu

News

Chat with Dr. Rafael Esteban Mur at 'Diario Médico' about the World Hepatitis C Day

Dr Rafael Esteban Mur, member of hepatic disease group at Vall d'Hebron Research Institute (VHIR) and head of internal medicine-liver service at Vall d'Hebron University Hospital, answered questions today in a chat about Hepatitis C in the journal 'Diario Médico' coinciding with the World Day of thi

News

Dr. Montalban debates on research in Multiple Sclerosis at TVE

Dr. Xavier Montalban, head of clinical neuroimmunology group at Vall d'Hebron Research Institute (VHIR) and the Multiple Sclerosis Center of Catalonia (CEM-Cat) has participated in a discussion of multiple sclerosis at TVE in the show 'Para todos la 2'. They have also intervened Dr. Pablo Villoslada

News

VHIR participates in the official start of EATRIS to developing Europe's translational research of the future

Today marks the official start of EATRIS, a pan-European network of translational research infrastructure in medicine. Building on a successful commencement phase funded by the European Commission in 2007-2010, Germany, Finland, Denmark, Italy, Spain and the Netherlands are parties to the new agree

News

The Princess of Asturias presents a cancer research grant from the AECC to Dr. Reventós

Her Royal Highness the Princess of Asturias, Letizia Ortiz, permanently President of Honor of the Spanish Association Against Cancer (AECC) has presented the Cancer Research Grants awarded by the Science Foundation of the AECC in the institutional event that has taken place in Zaragoza. One of the g

News

Identified key mechanisms in the biology of tumor stem cells

A team of researchers from Vall d'Hebron Research Institute (VHIR) has identified the mechanism used by cancer stem cells to protect against external attacks, the establishment of mechanisms of resistance and prevent differentiation to preserve its ability pluripotent, the ability to become any cell

News

VHIR participates in the III MTN Workshop

On 27 and 28 September took place in one of the rooms of the FC Barcelona Camp Nou stadium the III MuscleTech Workshop, which aims to improve the quality of life for people with muscle diseases and reduce the number of sports injuries with improved tools for tendinopathies. The network, called 'Musc

News

VHIR's Heart Area at the World Heart Day

The World Heart Day is an opportunity to increase the awareness of the population and of the administrations, politicians, productive sector and social agents of the enormous medical and economical burden of heart diseases in our society and in the world. A single heart disease, coronary artery dise

News

Members of the Russian Society of Ophthalmology attend a seminar by Dr. Simo at VHIR

More than 50 members of the Russian Society of Ophthalmology attended on Thursday September 22 a seminar by Dr. Rafael Simó, head of diabetes and metabolism group of Vall d'Hebron Research Institute (VHIR) at he conference room of the hospital. The group, formed by the most prestigious Russian eye s

News

The Spanish Society of Probiotics and Prebiotics is created with leadership of VHIR’s researchers

On September 21 was created the Spanish Society for Probiotics and Prebiotics (SEPyP), at Vall d’Hebron University Hospital, host of the new entity. The society will be chaired by Dr. Francisco Guarner, and in its board also will be Dr. Fernando Azpiroz, member and responsable respectively of the di

News

VHIR achieves a high success rate in the call for ISCIII health research projects

Vall d'Hebron Research Institute (VHIR) is the second Catalan biomedical center with more projects awarded in the call for health research projects in 2011 of the Instituto de Salud Carlos III (ISCIII). VHIR has been granted in 27 of its 55 projects presented, representing 49.09% of the success rate

News

Dr. Boada at World Alzheimer's Day

Coinciding with World Alzheimer's Day, Dr. Mercè Boada, head of the group of Alzheimer at Vall d'Hebron Research Institute (VHIR) and director of the ACE Foundation has participated in the program 'Els Matins' of TV3, and has been interviewed for various stories in other media. In addition, Dr. Boad